| Overview |
| bs-6051R-PE-Cy5.5 |
| Prostaglandin dehydrogenase 1 Antibody, PE-Cy5.5 Conjugated |
| WB |
| Human, Rat |
| Mouse, Cow, Pig, Horse, Rabbit |
| Specifications |
| PE-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Prostaglandin dehydrogenase 1 |
| 55-160/266 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3248 |
| P15428 |
| Cytoplasm |
| PGDH; PGDH1; PHOAR1; 15-PGDH; SDR36C1; 15-hydroxyprostaglandin dehydrogenase [NAD(+)]; Prostaglandin dehydrogenase 1; HPGD |
| Prostaglandin inactivation. Contributes to the regulation of events that are under the control of prostaglandin levels. Catalyzes the NAD-dependent dehydrogenation of lipoxin A4 to form 15-oxo-lipoxin A4. Inhibits in vivo proliferation of colon cancer cells. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz